Thermalin in the News
- Thermalin Diabetes targets $8M series B investment, eyes clinical trials
- Thermalin Diabetes snaps up $2.9 million in A round
- Thermalin Closes $2.85M Series A Round
- A Smarter Insulin: Professor Michael Weiss invesnts a zinc-stapled insulin that reduces cancer risks.
- Case Western Reserve University School of Medicine team discovers "smart" insulin protein molecule that could revolutionize diabetes care.
- Thermalin aims for better diabetes care without insulin side effects.
- Big Market, Bigger Mission
- Medical Mystery
- Thermalin Diabetes Follows the “Coulter Process” and Addresses Significant Needs in the Insulin Market
